Search research articles
Contact Us
Filters
Showing results (41-50 of 124) with videos related to
Page
of 13
Sort By:
Blood
|
August 21, 2016
Peripheral blood CD34<sup>+</sup> cells efficiently engraft human cytokine knock-in mice
Yasuyuki Saito, Jana M Ellegast, Anahita Rafiei, et al.
JACC. Advances
|
November 8, 2025
Clonal Hematopoiesis Risk Score (CHRS) Evaluation as a Prognostic Marker for Death in Cardio-Oncology Cohort
Jaiveer Singh, Rachel Jaber Chehayeb, Yunju Im, et al.
The Journal of Biological Chemistry
|
August 2, 2012
Up-regulation of translation eukaryotic initiation factor 4E in nucleophosmin 1 haploinsufficient cells results in changes in CCAAT enhancer-binding protein α activity: implications in myelodysplastic syndrome and acute myeloid leukemia
Arati Khanna-Gupta, Nirmalee Abayasekara, Michelle Levine, et al.
Experimental Hematology
|
May 22, 2020
Cyclosporine enhances the sensitivity to lenalidomide in MDS/AML in vitro
Xiaofei He, Aixia Dou, Saran Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2017
Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of Life
Rong Wang, Amer M Zeidan, Stephanie Halene, et al.
Nucleic Acids Research
|
May 7, 2022
Pre-mRNA splicing factor U2AF2 recognizes distinct conformations of nucleotide variants at the center of the pre-mRNA splice site signal
Eliezra Glasser, Debanjana Maji, Giulia Biancon, et al.
Haematologica
|
August 18, 2022
Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes
Melissa A Fischer, Yuanbin Song, Maria P Arrate, et al.
Leukemia
|
November 27, 2022
Prognostic implications of mono-hit and multi-hit TP53 alterations in patients with acute myeloid leukemia and higher risk myelodysplastic syndromes treated with azacitidine-based therapy
Amer M Zeidan, Jan Philipp Bewersdorf, Vanessa Hasle, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 6, 2012
Gaucher disease gene GBA functions in immune regulation
Jun Liu, Stephanie Halene, Mei Yang, et al.
Therapeutic Advances in Hematology
|
June 17, 2024
Integrated genetic, epigenetic, and immune landscape of <i>TP53</i> mutant AML and higher risk MDS treated with azacitidine
Amer M Zeidan, Jan Philipp Bewersdorf, Vanessa Hasle, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 124) with videos related to
Sort By:
Page
of 13
Blood
|
August 21, 2016
Peripheral blood CD34<sup>+</sup> cells efficiently engraft human cytokine knock-in mice
Yasuyuki Saito, Jana M Ellegast, Anahita Rafiei, et al.
JACC. Advances
|
November 8, 2025
Clonal Hematopoiesis Risk Score (CHRS) Evaluation as a Prognostic Marker for Death in Cardio-Oncology Cohort
Jaiveer Singh, Rachel Jaber Chehayeb, Yunju Im, et al.
The Journal of Biological Chemistry
|
August 2, 2012
Up-regulation of translation eukaryotic initiation factor 4E in nucleophosmin 1 haploinsufficient cells results in changes in CCAAT enhancer-binding protein α activity: implications in myelodysplastic syndrome and acute myeloid leukemia
Arati Khanna-Gupta, Nirmalee Abayasekara, Michelle Levine, et al.
Experimental Hematology
|
May 22, 2020
Cyclosporine enhances the sensitivity to lenalidomide in MDS/AML in vitro
Xiaofei He, Aixia Dou, Saran Feng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2017
Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of Life
Rong Wang, Amer M Zeidan, Stephanie Halene, et al.
Nucleic Acids Research
|
May 7, 2022
Pre-mRNA splicing factor U2AF2 recognizes distinct conformations of nucleotide variants at the center of the pre-mRNA splice site signal
Eliezra Glasser, Debanjana Maji, Giulia Biancon, et al.
Haematologica
|
August 18, 2022
Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes
Melissa A Fischer, Yuanbin Song, Maria P Arrate, et al.
Leukemia
|
November 27, 2022
Prognostic implications of mono-hit and multi-hit TP53 alterations in patients with acute myeloid leukemia and higher risk myelodysplastic syndromes treated with azacitidine-based therapy
Amer M Zeidan, Jan Philipp Bewersdorf, Vanessa Hasle, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 6, 2012
Gaucher disease gene GBA functions in immune regulation
Jun Liu, Stephanie Halene, Mei Yang, et al.
Therapeutic Advances in Hematology
|
June 17, 2024
Integrated genetic, epigenetic, and immune landscape of <i>TP53</i> mutant AML and higher risk MDS treated with azacitidine
Amer M Zeidan, Jan Philipp Bewersdorf, Vanessa Hasle, et al.
Page
of 13